PubMed Trending Research Digest — August 12, 2026

Automated digest · 95 articles · 15 research areas · August 12, 2026

Overview

Across this week’s PubMed highlights, a dominant theme is translational leverage: multiple studies aim to convert mechanistic insights into actionable diagnostics, therapeutics, or clinical decision tools. Examples include improved biomarker strategies (e.g., plasma tau multiprotein panels, glaucoma progression deep learning from fundus images, and antibody/biomarker interpretation frameworks in NMOSD/MOGAD), as well as “liquid biopsy” and other minimally invasive approaches to detect disease state and treatment response earlier.

A second major theme is immune modulation—both in cancer and beyond. Several papers focus on refining immunotherapies (new CAR-T manufacturing concepts, checkpoint bispecifics, long-term CAR T persistence, and mechanisms of anti–PD-1 resistance), while others extend immune engineering to chronic non-malignant disease (e.g., in vivo CAR T generation for SLE). In parallel, neuroimmune and systemic inflammatory pathways are emphasized: type I interferon–driven T-cell dysfunction in SLE, microbiota–STING neuroimmune signaling for comorbid pain/cognition, and mechanistic neurovascular injury pathways after stroke.

Finally, the digest shows strong mechanistic breadth in cell biology and metabolism: ferroptosis and metal/copper homeostasis (including copper-driven cuproptosis in prostate cancer and ferroptosis vulnerability via Sec recoding in AML), RNA/transcription control (sense–antisense RNA duplex regulation in malaria, Pol II termination regulation, and RNAi/AGO2 structural activation), and genome/replication organization (compartment integrity at G1/S, PIF1 helicase behavior, and early embryonic cytoplasmic lattice structure). Together, these studies underscore a field-wide push toward understanding causal molecular circuitry—then targeting it for improved outcomes.

---

CRISPR & Genome Engineering Methods

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial.

The BeNeBio study evaluated whether stepwise dose reduction via IL-17 and IL-23 inhibitor interval prolongation is non-inferior to usual care in patients with psoriasis who have stable low disease activity. The trial randomized patients in a pragmatic, open-label, multicentre design across hospitals in the Netherlands and Belgium to stepwise dose reduction versus usual care. If non-inferiority and safety are demonstrated, this approach could reduce unnecessary exposure to high-cost biologics while maintaining disease control.

van den Reek JMPA, van Riel CAM, Soenen R et al. · The Lancet regional health. Europe · (2026) · View on PubMed ↗ · Free PDF ↗

TIGRa: An ultra-compact programmable activator enabling multiplexed and efficient gene regulation.

The study developed TIGRa, a compact TIGR-TasR-derived programmable transcriptional activator, and tested it for multiplexed gene regulation in cells. TIGRa is less than half the size of dSpCas9-based activators while achieving comparable or greater activation efficiency and enabling simultaneous activation of up to 12 endogenous genes via its native TIGR array architecture. This compact, multiplex-capable, CRISPR-mechanism-distinct activator could improve in vivo feasibility for gene-regulation therapeutics.

Liu Z, Chen S, Wang W et al. · Cell stem cell · (2026) · View on PubMed ↗ · Free PDF ↗

Degrade Green Fluorescent Protein (deGradFP) Method in Trypanosoma brucei.

This methods paper describes the deGradFP technique adapted for the kinetoplastid parasite Trypanosoma brucei, where an anti-GFP nanobody targets GFP-fusion proteins to the endogenous ubiquitin–proteasome pathway for rapid degradation. The key finding is that deGradFP can be used to efficiently degrade kinetochore proteins in T. brucei that have low turnover rates, enabling faster functional perturbation than traditional approaches. Scientifically, it provides a practical, transferable tool for studying essential protein dynamics in T. brucei and related parasites.

Ishii M, Akiyoshi B · Methods in molecular biology (Clifton, N.J.) · (2026) · View on PubMed ↗

Protein Depletion in Caenorhabditis elegans Using the Auxin-Inducible Degradation System.

This Methods article describes how to use the auxin-inducible degradation (AID) system in the nematode Caenorhabditis elegans by CRISPR-mediated insertion of an AID degron into a gene of interest and crossing to strains expressing the Arabidopsis thaliana TIR1 F-box protein. The key finding is a practical workflow for generating degron knock-ins, assembling the SCF ubiquitin ligase complex (TIR1 with endogenous Skp and Cullin), and performing rapid, tissue-specific conditional protein depletion. This provides a scientifically significant, experimentally actionable approach for studying gene function with temporal control in C. elegans.

Ward JD · Methods in molecular biology (Clifton, N.J.) · (2026) · View on PubMed ↗

Optimal Resistance Exercise Strategies for Improving Bone Mineral Density in Middle-Aged and Older Adults: A Network Meta-Analysis Based on Exercise Intensity and Frequency.

This network meta-analysis of randomized controlled trials in middle-aged and older adults compared resistance exercise strategies varying by intensity and frequency to determine effects on bone mineral density (BMD) at different skeletal sites. The key finding is that the analysis framework (searching major databases, assessing risk of bias with Cochrane RoB 2, and using Stata 17.0 with standardized mean differences and ranking) identifies relative effectiveness patterns across exercise regimens, enabling determination of an “optimal” strategy by skeletal site. Scientifically and clinically, it supports evidence-based prescription of resistance training parameters to improve BMD in older populations.

Zhang W, Mei J, Li X et al. · Calcified tissue international · (2026) · View on PubMed ↗

---

Protein Degradation & Proteostasis

Lysine deficiency within a conserved lysine desert is critical for EEL-1/HUWE1 to support ubiquitin proteasome system function.

The study investigated how lysine residues in a conserved “lysine desert” region of the C. elegans EEL-1 protein (human HUWE1 ortholog) regulate ubiquitin–proteasome system function under stress. Genetic disruption of lysine availability within this conserved region impaired EEL-1/HUWE1 support for efficient ubiquitin proteasome activity. These findings identify a specific, conserved lysine-dependent requirement for HUWE1/EEL-1-mediated proteostasis, informing mechanisms relevant to stress tolerance and age-related neurodegeneration.

Yanagi KS, Chen BJ, Kunjo SO et al. · PLoS genetics · (2026) · View on PubMed ↗ · Free PDF ↗

---

RNA Biology & Transcription/Translation Control

The Endoterpenoid System: A Membrane-Based Logic Framework for Integrating Cannabinoid, Olfactory, and Lipid-Sensitive Receptor Crosstalk.

This article proposes the “Endoterpenoid System” (ETS), a membrane-based logic framework integrating classical endocannabinoid signaling with ectopically expressed olfactory GPCRs, ion channels, and microbially derived terpenoids. The key concept is that an “endoterpenoidome” (eTBome) of lipophilic cannabinoids/terpenoids partitions into cholesterol-rich lipid rafts, enabling receptor crosstalk via heteromerization and β-arrestin-scaffolded signalosomes. The significance is a unifying mechanistic model that could guide future experimental work on how cannabinoid, olfactory, and lipid-raft–dependent signaling interact to produce emergent biological responses.

Yarar E, Altundag A, Mason CE et al. · Journal of neuroscience research · (2026) · View on PubMed ↗

Mechanisms of transcription termination across the coding and noncoding loci of the genome.

This review summarized mechanisms of RNA polymerase II (Pol II) transcription termination across coding and noncoding genomic loci, emphasizing that termination is regulated rather than a passive elongation endpoint. It integrates major termination pathways—especially canonical cleavage and polyadenylation-dependent termination—along with context-dependent regulation affecting gene expression, RNA surveillance, and chromatin environments, drawing primarily from metazoan studies with supporting yeast insights. The work is significant for understanding how termination shapes transcriptomes and for identifying molecular targets relevant to transcriptional dysregulation in disease.

Song A, Hu M, Chen FX · Nature reviews. Molecular cell biology · (2026) · View on PubMed ↗

Sense-Antisense RNA duplexes mediate stress-responsive translational control in Plasmodium falciparum.

This study investigated how sense–antisense RNA duplexes mediate stress-responsive translational control in the malaria parasite Plasmodium falciparum. It showed that antisense transcription is widespread and regulated under environmental stress and that sense–antisense RNA duplex formation contributes to translational regulation despite a limited set of canonical transcription factors. The significance is that it uncovers a regulatory RNA mechanism that could be exploited to understand parasite adaptation and potentially identify new targets for malaria intervention.

Malhotra R, Pandit K, Malhotra P et al. · RNA (New York, N.Y.) · (2026) · View on PubMed ↗

An antisense method for efficient exon skipping and its application to Duchenne muscular dystrophy.

This PNAS study developed a bipartite antisense oligonucleotide (ASO) design called 5’ splice site decoy (5D)-ASO to enhance exon skipping for Duchenne muscular dystrophy (DMD) by improving splicing repression. The key finding was that adding a short tail sequence that interferes with U1 snRNA recognition of the target exon’s 5’ splice site markedly increased exon skipping efficiency. This is scientifically significant because it offers a more robust ASO design strategy that could improve the therapeutic performance of exon-skipping approaches for DMD.

Feng P, Gao P, Meng S et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗ · Free PDF ↗

Central guide-target pairing activates human Argonaute2 by uncoupling the N-PAZ and MID-PIWI lobes.

This PNAS study used cryo-EM structures and biochemical assays to determine how central guide–target pairing activates human Argonaute 2 (AGO2) for siRNA-mediated cleavage. It found that centrally mismatched targets propagate through AGO2’s nucleic-acid binding channel, while centrally matched targets pry open the tapered channel, collapsing AGO2’s bilobed architecture into a duplex-bound MID-PIWI lobe and an RNA-free N-PAZ lobe to generate a preactive open intermediate. This mechanistic insight is significant for understanding the molecular basis of siRNA target complementarity requirements and for improving RNAi design.

Zhang H, Savidge A, Sim G et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗

Nucleocapsid-like cryoEM structure of influenza B virus.

This PLoS Pathogens study determined a nucleocapsid-like cryoEM structure of influenza B virus, focusing on the viral ribonucleoprotein (vRNP) core formed by multiple nucleoprotein (NP) copies and the polymerase complex. It emphasized that influenza B NP uniquely contains an extended, disordered N-terminal tail (~70 amino acids) required for nuclear localization, and the structure provides a basis for understanding how this tail may contribute to vRNP function. The findings are significant because they advance structural understanding of influenza B replication machinery, which can inform antiviral target discovery and rational drug design.

Thirion M, Stelfox AJ, Chenavier F et al. · PLoS pathogens · (2026) · View on PubMed ↗ · Free PDF ↗

---

Genome Organization & DNA Replication

In-situ cryo-ET of mouse embryos reveals cytoplasmic lattices contain ubiquitin-charged E2-E3 ligase assemblies.

This study used cryo-focused ion beam milling and cryo-electron tomography to determine the in situ structure of cytoplasmic lattices (CPLs) in 6/8-cell mouse embryos. The authors resolved CPLs at ~4.7 Å and found filaments composed of multiple copies of at least fourteen proteins arranged into a ~4.5 MDa repeating unit with a central cavity. Scientifically, it provides direct structural insight into how CPLs are organized during early mammalian development, enabling mechanistic hypotheses for their roles in organelle organization and protein homeostasis.

Singh K, Harasimov K, Niakan KK et al. · The EMBO journal · (2026) · View on PubMed ↗ · Free PDF ↗

Nuclear compartmentalization at the G1/S transition plays a key role in DNA replication control.

This study investigated how nuclear compartmentalization at the G1/S transition controls DNA replication by using a genome-wide loss-of-function CRISPR screen in mammalian cells. It identified GINS4, a component of the replicative DNA helicase complex, as essential for proper segregation of A/B chromatin compartments during the G1-to-S transition, and GINS4 depletion disrupted A/B organization. Scientifically, it links spatial genome organization to replication control, suggesting that compartment integrity is a functional requirement for faithful S-phase entry.

Oji A, Yusa K, Noda I et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

Human PIF1 clears secondary DNA structures by coupled DNA unwinding and rewinding activities.

This study compared full-length human PIF1 helicase (hPIF1) with budding yeast Pif1 (yPif1) using bulk DNA unwinding/annealing assays and single-molecule magnetic tweezers. hPIF1 showed weak apparent net unwinding because its strong intrinsic ssDNA annealing rapidly re-forms duplex DNA behind the motor, while single-molecule data indicated it is only modestly slower and similarly processive to yPif1. These mechanistic insights clarify how human PIF1 couples unwinding with reannealing to clear secondary DNA structures and thereby support genome stability during replication and repair.

Jayachandran A, Mütze M, Romaniuk K et al. · Genes & development · (2026) · View on PubMed ↗ · Free PDF ↗

---

Ubiquitin/ER Stress & Proteostasis Pathways

RNF5 promotes acute lung injury through HSPA5 ER-to-cytosol translocation and resultant PERK activation.

This study investigated how the E3 ubiquitin ligase RNF5 contributes to acute lung injury/ARDS by regulating ER stress signaling. RNF5 was upregulated in ALI and promoted HSPA5 translocation from the ER to the cytosol, which in turn activated PERK and exacerbated lung injury, while in vivo Rnf5 ablation attenuated pulmonary edema and inflammatory infiltration. Clinically, it identifies the RNF5–HSPA5–PERK axis as a mechanistic driver and a potential therapeutic target for ALI/ARDS.

Sun YZ, Li XY, Wang J et al. · Cell death and differentiation · (2026) · View on PubMed ↗

Genetic and pharmaceutical targeting of Suv39h1 ameliorates renal fibrosis by unlocking CXCL10 transcription.

This study investigated how genetic and pharmacologic targeting of the lysine methyltransferase Suv39h1 affects renal fibrosis by regulating CXCL10 transcription in fibroblast-to-myofibroblast transition. Using fibroblast- and myofibroblast-specific gene knockouts in mice driven by Col1a2-CreERT2 and Postn-CreERT2, and inducing renal fibrosis with unilateral ureteral obstruction (UUO) or streptozotocin (STZ) (details truncated), the authors report that Suv39h1 targeting ameliorates fibrosis by unlocking CXCL10 transcription. The work identifies Suv39h1–CXCL10 regulatory control as a potential therapeutic axis for chronic kidney disease–associated fibrosis.

Wu X, Luo Y, Wu C et al. · Journal of advanced research · (2026) · View on PubMed ↗ · Free PDF ↗

Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.

This Hepatology study investigated how the hepatocyte RNA-binding protein hnRNPK (gene: HNRNPK) preserves mitochondrial integrity to restrain liver injury and fibrosis across human and murine fibrotic etiologies. By integrating snRNA-seq, hepatocyte-specific alternative splicing profiling, untargeted and spatial metabolomics, and 3D mitochondrial reconstruction using AT-SEM, it identified hnRNPK abundance reduction in fibrotic states and delineated hnRNPK-mediated splicing dysregulation that impacts mitochondrial integrity. The work is clinically significant because it positions hnRNPK as a potential therapeutic lever to limit mitochondrial damage and thereby reduce liver fibrosis.

Peng Q, Wang S, Zhang Y et al. · Hepatology (Baltimore, Md.) · (2026) · View on PubMed ↗

---

Neurodegeneration & Biomarkers (Alzheimer’s/Parkinson’s/Tau/NfL)

Neurobiological markers across joint profiles of subjective cognitive decline and objective cognitive function in older adults.

This study examined neurobiological markers in 648 older adults from the IGNITE exercise trial, stratifying participants into profiles that combined subjective cognitive decline with objective cognitive performance. Plasma neurofilament light chain (NfL), phosphorylated tau 217 (p-tau217), GFAP, and MRI-based volumetric Alzheimer’s disease atrophy signatures (plus brain-predicted age difference) differed across the subjective–objective cognitive profiles, indicating distinct underlying neurodegenerative and neuroinflammatory states. These findings support using multimodal biomarkers to clarify why subjective cognitive concerns can diverge from objective impairment in cognitively unimpaired aging and may improve risk stratification for preclinical cognitive decline.

Wan L, Kang C, Harrison R et al. · Alzheimer’s & dementia : the journal of the Alzheimer’s Association · (2026) · View on PubMed ↗

The structural basis for LRRK2’s activation and autoinhibition.

The study investigated how leucine-rich repeat kinase 2 (LRRK2) switches between autoinhibited and active states, focusing on the ROC GTPase control mechanism, using cryo-electron microscopy, biochemical reconstitution, and cell-based assays. GTP binding promoted LRRK2 activation whereas GDP binding enforced autoinhibition, and PD-linked mutations G2019S and R1441C/G/H activated LRRK2 through distinct structural mechanisms. This mechanistic framework supports rational therapeutic strategies aimed at modulating LRRK2 kinase activity in Parkinson’s disease.

Villagran Suarez A, Hatch KS, Bodrug T et al. · Cell · (2026) · View on PubMed ↗ · Free PDF ↗

Selective loss of primary cilia and neurotrophic signaling in G51D α-synuclein mice highlights a common pathway to Parkinson’s disease.

This PNAS study used G51D α-synuclein knock-in mice to test whether selective loss of primary cilia and neurotrophic signaling—previously observed in other Parkinson’s disease models—also occurs in this genetically relevant model. It showed that G51D α-synuclein mice share these phenotypes, with phospho-Ser129 α-synuclein accumulation correlating with cilia loss in striatal cholinergic interneurons. The findings are significant because they support a common pathway linking cilia dysfunction and neurotrophic signaling to Parkinson’s disease progression.

Lin YE, Jaimon E, Kim Y et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗ · Free PDF ↗

Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities.

This review evaluates semaglutide, a GLP-1 receptor agonist, as a potential neuroprotective therapy across preclinical models of Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and stroke. The key finding is that semaglutide has been reported to reduce neuroinflammatory and oxidative stress markers and improve some pathological or behavioral outcomes, but effects vary by disease model and indication, and major translational hurdles remain (including failed Phase 3 EVOKE and EVOKE+ cognitive endpoints in early symptomatic Alzheimer’s disease). Clinically, the synthesis highlights both mechanistic promise and the need for better translation strategies for GLP-1–based neuroprotection.

Mukim RD, Xu Y, Evola V et al. · Molecular biology reports · (2026) · View on PubMed ↗

---

Neuroinflammation & Immune Dysregulation (SLE, IFN, neuroimmune)

Intermittent fasting alleviates neuropathic pain and cognitive deficits via an Alistipes finegoldii-Hippuric Acid-STING neuroimmune axis.

This study tested whether intermittent fasting (IF) improves neuropathic pain and cognitive deficits in chronic pain models, focusing on a gut microbiota–STING neuroimmune pathway. IF reduced mechanical allodynia, thermal hyperalgesia, and cognitive deficits (including in the chronic constriction injury model) and reshaped the microbiota with Alistipes finegoldii as a consistently enriched species; live A. finegoldii supplementation reproduced IF’s analgesic and pro-cognitive effects, implicating an Alistipes finegoldii–hippuric acid–STING axis (details truncated). These findings support a microbiota-targeted, non-pharmacologic strategy for treating comorbid pain and cognitive impairment via STING-linked neuroimmune signaling.

Ding X, Qiu D, Li XY et al. · Brain, behavior, and immunity · (2026) · View on PubMed ↗

Type I interferon drives dysfunction of a distinct CD8+ HLA-DRB1+ T cell subset in systemic lupus erythematosus.

This study examined type I interferon (IFN-α)–driven dysfunction of a CD8+ HLA-DRB1+ T cell subset in peripheral blood from 11 patients with systemic lupus erythematosus (SLE) and 12 healthy controls, using flow cytometry plus single-cell RNA sequencing and TCR sequencing with and without IFN-α stimulation. The authors found that IFN-α signaling promotes aberrant HLA-DRB1 expression and expansion of a distinct CD8+ HLA-DRB1+ subset with transcriptional features consistent with exhaustion/senescence and impaired function. These findings link type I IFN biology to adaptive immune dysregulation in SLE and support HLA-DRB1+ CD8+ T cells as a mechanistic, potentially targetable biomarker population in IFN-driven disease.

Long H, Carmona E, Dozmorov MG et al. · Arthritis & rheumatology (Hoboken, N.J.) · (2026) · View on PubMed ↗ · Free PDF ↗

---

Cancer Immunotherapy (CAR-T/TCR/Checkpoint/Immunotherapy Resistance)

Establishment of a scalable engineered cell-line platform for direct, GMP-grade production of eVLP vectors enabling streamlined generation of gene-edited CAR-T/NK cells.

This article reports a scalable, engineered monoclonal producer cell-line platform for direct, GMP-grade production of engineered virus-like particles (eVLPs) that co-package CRISPR-Cas9 Cas9-gRNA ribonucleoproteins (RNPs) for streamlined generation of gene-edited CAR-T and CAR-NK cells. The key advance is continuous, scalable eVLP manufacturing using integrated producer-cell modules (e.g., Gag-Pol and Gag-Ca) to reduce cost and batch-to-batch variability compared with conventional viral/electroporation manufacturing. This platform is significant because it could accelerate clinical translation of CRISPR-edited CAR therapies by improving manufacturing consistency and regulatory feasibility.

Lin W, Shi J, Chen H et al. · Frontiers in immunology · (2026) · View on PubMed ↗ · Free PDF ↗

Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

This clinical study followed 38 patients with non-Hodgkin lymphoma to assess decade-long persistence and characteristics of 4-1BB-costimulated anti-CD19 CAR T cells (CART19) after infusion. CAR19 transgene detection persisted up to 10 years in a subset of long-term responders, and in some patients ongoing B cell aplasia suggested sustained functional activity, with one patient showing CART19 cells comprising 1.2% of circulating T cells at 10.1 years. The findings are significant for understanding long-term CAR T cell biology, durability of remission, and potential biomarkers of persistent activity beyond five years.

Paruzzo L, Chong ER, Chong EA et al. · Nature medicine · (2026) · View on PubMed ↗ · Free PDF ↗

CAR T cell therapy beyond cancer: current status, challenges and future prospects.

This review summarized how chimeric antigen receptor (CAR) T-cell therapy concepts can be adapted beyond cancer to target long-lived pathological cell populations in chronic non-malignant diseases. It highlights key challenges (e.g., targeting disease-sustaining cellular compartments, persistence, and safety) and discusses engineering approaches using different co-stimulatory domains such as CD28 and 4-1BB to tune CAR T-cell behavior. The significance is that it provides a roadmap for translating CAR design principles from oncology to viral reservoirs, autoreactive B/plasma cells, activated fibroblasts, alloimmune clones, and senescent cells.

Upadhyay S, Cho S, Upmanyu K et al. · Signal transduction and targeted therapy · (2026) · View on PubMed ↗ · Free PDF ↗

Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.

This report provides 5-year follow-up outcomes from the open-label phase III CheckMate 648 trial in previously untreated advanced esophageal squamous cell carcinoma (ESCC), comparing nivolumab plus chemotherapy, nivolumab plus ipilimumab, and chemotherapy alone. Both nivolumab-containing regimens previously improved overall survival versus chemotherapy, and this publication extends OS and additional analyses to at least 5 years (full results truncated). Long-term efficacy data support durable benefit of checkpoint inhibitor combinations in advanced ESCC and inform long-term treatment decisions.

Kato K, Ajani J, Doki Y et al. · Annals of oncology : official journal of the European Society for Medical Oncology · (2026) · View on PubMed ↗

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

This study used integrated TCR profiling, HLA immunopeptidomics, and functional screening to characterize tumor-reactive T cells in the bone marrow microenvironment of patients with multiple myeloma (MM) and acute myeloid leukemia (AML). It found that latent effector T cells display a conserved effector transcriptional program distinct from exhausted tumor-reactive T cells seen in solid cancers, and that immunopeptidomics revealed a partially shared antigen landscape enriched for noncanonical peptides driving convergent TCR responses. These findings improve understanding of how T cells mediate immunotherapy-relevant surveillance in bone marrow malignancies and may guide future immunotherapeutic targeting strategies.

Kehl N, Wagner TR, Steiger S et al. · Cancer cell · (2026) · View on PubMed ↗ · Free PDF ↗

Beyond BCL-2: What drives venetoclax resistance in acute myeloid leukemia?

This article reviewed and synthesized emerging evidence on mechanisms of resistance to the BCL-2 inhibitor venetoclax in acute myeloid leukemia (AML), particularly beyond canonical BCL-2 dependence. It highlights validated and putative resistance routes including compensatory shifts toward MCL-1 or BCL-xL dependence, oncogenic signaling activation, altered blast phenotype/differentiation stage, and additional candidates such as BAX mutations, mitochondrial remodeling, integrated stress response, and metabolic adaptations (enhanced amino acid uptake and fatty acid oxidation to sustain oxidative phosphorylation). Clarifying these pathways is clinically significant for guiding combination therapies and overcoming venetoclax resistance in AML patients.

Skwarska A, Konopleva M · Cancer cell · (2026) · View on PubMed ↗

In vivo generation of CD19 CAR T cells for the treatment of mouse systemic lupus erythematosus.

The study developed an in vivo engineered CD19 CAR T-cell system for systemic lupus erythematosus (SLE) using CD5-targeted lipid nanoparticles (aCD5-CD19/LNP) delivering CD19-directed CAR mRNA, and tested it in the MRL/lpr murine SLE model. The aCD5-CD19/LNP platform generated functional CAR T cells that targeted CD19+ B cells in vitro and showed therapeutic activity in vivo in the SLE model. This approach could simplify CAR T manufacturing by enabling in vivo CAR T generation for autoimmune indications like SLE.

Xie H, Chen D, Lin Z et al. · International immunopharmacology · (2026) · View on PubMed ↗

The G-quadruplex ligand CX-5461 inhibits laryngeal cancer via inducing immunogenic cell death and remodeling the tumor immune microenvironment.

The study assessed clinical relevance of G-quadruplex (G4) accumulation in laryngeal cancer and tested the G4 ligand CX-5461 for antitumor and immunomodulatory effects. Using immunohistochemistry (IHC) and Kaplan–Meier analyses, it evaluated whether G4 levels in tumor versus adjacent normal tissues correlate with prognosis, and then examined CX-5461’s effects in vitro and in vivo (details truncated). If CX-5461 induces immunogenic cell death and remodels the tumor immune microenvironment as proposed, it could represent a mechanism-based immunotherapy strategy for laryngeal cancer targeting G4 structures.

Teng FY, Zhang B, Liu YX et al. · International immunopharmacology · (2026) · View on PubMed ↗

Single-cell multiomics identifies an ALDH9A1-carnitine signaling axis driving resistance of NSCLC to immunotherapy.

This PNAS study used integrated single-cell multiomics—including CODEX, metabolomics, CyTOF, ATAC-seq, and single-cell spatial transcriptomics—to define mechanisms of resistance to anti–PD-1 therapy in non-small cell lung cancer (NSCLC) and tested them in mouse models. It identified an ALDH9A1-driven carnitine/acetyl-CoA axis that promotes anti–PD-1 resistance, where ALDH9A1 loss restrained tumor growth in immunocompetent but not immunocompromised mice and was associated with increased tertiary lymphoid structure maturation and reduced protumorigenic MDSCs. The findings are clinically significant because they nominate ALDH9A1 as a mechanistic biomarker and potential target to overcome immunotherapy resistance in NSCLC.

Du H, Lang T, Zha X et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗

PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.

This preclinical study evaluated PARP inhibitors plus anlotinib as bridging therapy to improve armored CAR-T cell performance in ovarian cancer, focusing on intratumoral trafficking and immune activation. In immunocompetent mice, the combination induced durable intratumoral T-cell accumulation associated with activation of the cGAS–STING pathway and vascular normalization, improving antitumor efficacy. The findings are clinically relevant because they propose a drug-bridging strategy to enhance solid-tumor CAR-T infiltration without exposing CAR-T cells to concomitant drugs.

Li H, Xiang M, Xu Q et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · (2026) · View on PubMed ↗ · Free PDF ↗

Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.

This first-in-human phase I/II study investigated rilvegostomig, an anti–PD-1/TIGIT bispecific antibody, in checkpoint inhibitor–experienced, PD-L1–positive advanced or metastatic non-small-cell lung cancer (NSCLC). Patients received escalating intravenous doses (70, 210, 750, 1500 mg Q3W) followed by dose expansion, with the trial assessing safety, pharmacodynamics/pharmacokinetics, and preliminary antitumor activity. The study is significant as it establishes early clinical tolerability and activity signals for a novel PD-1/TIGIT bispecific in a CPI-experienced NSCLC population.

Rohrberg KS, Brandão M, Castañón Álvarez E et al. · Clinical cancer research : an official journal of the American Association for Cancer Research · (2026) · View on PubMed ↗ · Free PDF ↗

---

Cancer Biology & Tumor Microenvironment (TME), Metabolism, Microbiome

Trans-regulatory gene mapping prioritizes disease drivers in asthma.

This study introduced DANDELION, a mediation-inspired framework that prioritizes disease-proximal genes (DPGs) by integrating trans-regulatory effects from disease-relevant tissues with gene-level burden from whole-exome sequencing, and applied it to asthma. DANDELION identified novel DPGs that conventional approaches missed, and the abstract indicates validation using CRISPR screens in airway epithelial cells. The scientific significance is that it provides a trans-regulatory gene-mapping strategy to pinpoint causal drivers in asthma, enabling more targeted mechanistic and therapeutic follow-up.

Salamone IM, Tian P, Qi Z et al. · Cell · (2026) · View on PubMed ↗

The sex and reproductive plasticity of intestinal muscles instruct gut size.

This work studied how intestinal muscle controls adult gut size in Drosophila, focusing on sex and reproductive status and testing whether muscle-intrinsic sex determinants set baseline differences. It found that gut size is extrinsically controlled by surrounding intestinal muscles, with female muscles growing during reproduction and sex/reproductive status changes in muscle cells shifting myofibril width and organ size. The significance is that it reveals a hormone- and nutrition-integrating muscle program that instructs organ growth, reframing gut size regulation beyond stem-cell dynamics.

Mineo A, Blackie L, Milona A et al. · Cell · (2026) · View on PubMed ↗

Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer.

This preclinical study used single-cell transcriptomic sequencing to examine how fasting-mimicking diets (FMD) reprogram cancer-associated fibroblasts and the tumor microenvironment in a mouse model of spontaneous breast cancer. FMD suppressed tumor cell stemness, promoted apoptosis, and increased infiltration of innate and adaptive immune cells, particularly natural killer (NK) cells and effector CD8+ T cells. The significance is that FMD can reverse immunosuppression in the breast cancer microenvironment, supporting potential combination strategies with immunotherapies.

Zhang J, Li N, Li R et al. · Cancer research · (2026) · View on PubMed ↗

Prevalence and chronology of colibactin-associated mutational processes and their microbiome spectra in Japanese colorectal cancer.

This study investigated colibactin-associated mutational processes and their microbiome spectra in Japanese colorectal cancer by integrating whole-genome sequencing (WGS) and transcriptome profiling of tumors with whole-genome metagenomic sequencing of fecal samples. Using interpretable artificial intelligence, the authors stratified colorectal cancer into four microbiome-informed subtypes and linked specific colibactin-associated mutational signatures to distinct gut microbiome patterns. Scientifically, it provides high-resolution host–microbiome evidence for colibactin-driven carcinogenesis and suggests microbiome-informed subtyping that could guide future prevention or stratified interventions.

Shiba S, Yachida S, Mizutani S et al. · Nature genetics · (2026) · View on PubMed ↗

Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE.

The study analyzed trastuzumab deruxtecan (T-DXd) rechallenge outcomes in HER2-positive metastatic breast cancer using a post-hoc subgroup analysis of the EN-SEMBLE nationwide Japanese cohort (N=664). Among 26 rechallenged patients, the real-world median progression-free survival, time to treatment failure, and overall survival were 6.5, 4.9, and 14.2 months, with an objective response rate of 27%, and patients who stopped initial T-DXd without progression showed numerically longer real-world progression outcomes. These real-world data support the feasibility and potential benefit of T-DXd rechallenge in selected HER2-positive mBC patients.

Nozawa K, Iwata H, Mukohara T et al. · Breast (Edinburgh, Scotland) · (2026) · View on PubMed ↗ · Free PDF ↗

Formononetin Antagonizes Osteosarcoma Metastasis by Targeting CD44: An Integrated Multi-Omics Study.

The study used integrated multi-omics approaches—bulk RNA-seq, single-cell RNA-seq, and spatial transcriptomics—on osteosarcoma (OS) patient data to identify a chemoresistant, metastasis-prone OS subpopulation and then tested the natural compound formononetin (FMN) mechanistically. It reports that FMN antagonizes OS metastasis by targeting CD44, linking endothelial dysfunction and the pro-metastatic program of the identified OS subpopulation to metastatic behavior. This provides a CD44-centered rationale for developing FMN or related agents to suppress OS metastasis, particularly in chemoresistant disease states.

Feng W, Dai W, Wei G et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · (2026) · View on PubMed ↗

The gut-kidney axis revisited: Integrating gut microbiota, autophagy and metabolomics in chronic kidney disease.

This review integrates evidence on gut microbiota alterations, autophagy, and metabolomics to explain how the gut–kidney axis contributes to chronic kidney disease (CKD) progression. It summarizes associations between CKD and gut dysbiosis—particularly depletion of short-chain fatty acid (SCFA)-producing bacteria and enrichment of proteolytic/uremic toxin-generating microbes—linking these changes to renal inflammation, fibrosis, and cardiovascular complications. The synthesis is clinically significant because it frames CKD as a systemic, network-driven disorder and highlights potential multi-target intervention points beyond slowing renal decline.

Lidoo K, Kaur R, Singh R et al. · International immunopharmacology · (2026) · View on PubMed ↗

Lipid droplets confer SA-dependent antiviral defense without growth penalty.

This PNAS study investigated how lipid droplets (LDs) contribute to antiviral defense in plants using barley stripe mosaic virus (BSMV) infection in Nicotiana benthamiana and wheat. Using split-TurboID-based proximity labeling, it identified LD-associated proteins at ER–chloroplast contact sites and showed that increasing LD formation (e.g., via overexpressing mouse FIT2 or plant NbLDAP2.1) reduced viral accumulation, whereas impairing LD formation increased infection. The work is significant because it reveals an LD-based, actin-dependent defense mechanism that could inform strategies to enhance crop resistance to (+)ssRNA plant viruses.

Zhou L, Wen Z, Zhong C et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗

Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

This prospective multicountry analysis studied pediatric PAX5-rearranged B-acute lymphoblastic leukemia (PAX5-r ALL) in 159 children treated in AIEOP-BFM ALL trials across Italy, Germany, and Austria. PAX5-r ALL showed unfavorable risk features and measurable residual disease (MRD)-dependent outcomes, with higher-risk clinical characteristics compared with non–PAX5-r cohorts. The results support MRD-informed risk stratification for children with PAX5-r ALL to guide intensity of therapy.

Peccatori N, Curto A, Silvestri D et al. · Blood · (2026) · View on PubMed ↗

Stress granules confer an early vulnerability in KRAS-driven pancreatic tumorigenesis.

The study investigated whether stress granules (SGs) enable KRAS-driven pancreatic tumor initiation by using KRAS-mutant acinar cells and pancreatic tumor models. SG formation was required for KRAS-mutant cells to progress from stressed acinar states to preneoplastic lesions, and blocking SGs prevented KRAS-driven acinar-to-ductal metaplasia ex vivo and reduced preneoplastic lesion formation in vivo. This identifies SGs as an early vulnerability in KRAS-driven pancreatic tumorigenesis, suggesting a potential therapeutic strategy to block adaptation to oncogenic stress.

Estaras M, Cosialls E, Pollin G et al. · Cell reports · (2026) · View on PubMed ↗ · Free PDF ↗

Distinct endogenous retroviruses are expressed in mutational subtypes of clear cell renal cell carcinoma and are linked to improved clinical outcomes.

This study characterized endogenous retroviruses (ERVs) expressed across mutational subtypes of clear cell renal cell carcinoma (ccRCC) and linked specific ERV expression patterns to clinical outcomes. ERVs 544 and 2014 were upregulated in PBRM1-mutant samples, and high expression of these ERVs together with somatic PBRM1 mutations was associated with improved patient outcomes. The work is significant because it connects chromatin regulator mutations (PBRM1) to ERV-driven biology that may underlie better prognosis and potentially immunotherapy responsiveness.

Meli K, Ricker CA, Camp SY et al. · Cell reports · (2026) · View on PubMed ↗ · Free PDF ↗

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

In a multicenter, randomized, open-label phase 3 trial in China, this study compared first-line osimertinib plus chemotherapy versus osimertinib monotherapy in patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) harboring concurrent TP53 mutations. The key finding was that adding chemotherapy to osimertinib improved efficacy outcomes compared with osimertinib alone while maintaining an acceptable safety profile for this molecularly defined subgroup. Clinically, it provides evidence for selecting combination therapy specifically for EGFR/TP53 co-mutated advanced NSCLC patients.

Zhou T, Zhou H, Gao F et al. · JAMA · (2026) · 1 citations · View on PubMed ↗

---

Ferroptosis & Metal/Copper/Iron Metabolism

EP300-Mediated MTF1-K218 Lactylation Buffers AR-Driven Copper Overload to Suppress Cuproptosis in Castration-Resistant Prostate Cancer.

This study investigated how EP300-mediated MTF1-K218 lactylation buffers androgen receptor (AR)–driven copper overload to suppress cuproptosis in castration-resistant prostate cancer (CRPC). It found that tumor copper levels correlate with AR activity, that AR hyperactivation causes pathological copper accumulation while inducing tolerance, and that the buffering mechanism is mediated by metal-responsive transcription factor 1 (MTF1) via lactylation at K218. The significance is a mechanistic target (EP300–MTF1 lactylation) that could be exploited to modulate copper homeostasis and enhance cuproptosis-based therapies in CRPC.

Li K, Wei Y, Li Y et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · (2026) · View on PubMed ↗

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction.

This study investigated whether ABHD11-mediated mitochondrial DNA (mtDNA) transcription restores mitochondrial function and attenuates cardiomyocyte ferroptosis after myocardial infarction (MI). Using MI models and time-course analyses with cell-death inhibitor comparisons, the authors identified ABHD11-dependent mtDNA transcription as a key molecular regulator that mitigates ferroptosis-driven mitochondrial dysfunction in cardiomyocytes. Clinically, targeting the ABHD11–mtDNA transcription axis could represent a novel ferroptosis-modulating therapeutic strategy to reduce ischemic myocardial injury after MI.

Liu Y, Chen Y, Zheng H et al. · Circulation · (2026) · View on PubMed ↗ · Free PDF ↗

Ferroptosis in T cells: mechanisms, biology and translational opportunities.

This review article synthesized current mechanistic knowledge on ferroptosis in T cells, focusing on how iron metabolism, lipid peroxidation, and redox networks regulate ferroptotic sensitivity and T-cell function. It highlights pathways such as transferrin receptor 1–mTOR signaling controlling iron-dependent activation, lipid peroxidation driving vulnerability in tumor-infiltrating CD8+ T cells, and redox balance maintaining T-cell survival. Translationally, the review frames ferroptosis modulation as a potential strategy to reshape anti-tumor immunity and improve outcomes in cancer immunotherapy.

Song J, Wu Q, Green DR et al. · Nature reviews. Immunology · (2026) · View on PubMed ↗

Targeting oncogenic FLT3 uncovers a ferroptosis vulnerability through selenocysteine recoding in acute myeloid leukaemia.

This study tested whether targeting oncogenic FLT3 can create a ferroptosis vulnerability in acute myeloid leukemia by disrupting selenocysteine (Sec) recoding. In a drug screening using a selenoprotein translation reporter, FLT3 inhibitors suppressed selenoprotein translation and induced ferroptosis in FLT3-mutant AML, mechanistically impairing UGA-to-selenocysteine recoding via the SECIS-dependent selenoprotein biosynthesis pathway. These results identify FLT3 inhibition as a therapeutic approach that couples oncogenic targeting to ferroptosis induction through Sec recoding, offering a potential route for treating therapy-resistant AML.

Li M, Zhu Y, Kageyama Y et al. · Nature cell biology · (2026) · View on PubMed ↗ · Free PDF ↗

The hepatic FGFR-ERK-HRG axis regulates heparin-induced thrombocytopenia with thrombosis.

The study examined the hepatic FGFR–ERK–HRG signaling axis in a model of heparin-induced thrombocytopenia with thrombosis (HIT). Repeated heparin administration over five days enhanced platelet activation, and plasma proteomics showed histidine-rich glycoprotein (HRG) levels decreased after successive heparin dosing and inversely related to platelet activation. These data link liver signaling (FGFR–ERK) and HRG regulation to HIT immune-complex initiation and thrombosis development, suggesting potential mechanistic targets.

Zhou S, Wang T, Neves MAD et al. · Blood · (2026) · View on PubMed ↗

---

Cardiovascular Disease & Shock/Ischemia-Reperfusion

Ultra-early versus early adjunctive vasopressin initiation after norepinephrine escalation in septic shock: a target trial emulation.

This target trial emulation used electronic health record databases (MIMIC-IV 2008–2022 and eICU-CRD 2014–2015) to compare ultra-early versus early adjunctive vasopressin initiation after norepinephrine escalation in adults with septic shock. It defined ultra-early vasopressin as initiation within 0–3 hours and early as >3–6 hours after the norepinephrine infusion rate reached ≥0.25 μg/kg/min, using clone-censor-weight methods to estimate cumulative incidence under each strategy. The significance is that it aims to clarify optimal vasopressin timing to improve outcomes in septic shock when norepinephrine escalation has already occurred.

Nakashima T, Ichinomiya T, Nakajima M et al. · Intensive care medicine · (2026) · View on PubMed ↗

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

This study examined how RUNX1-driven endothelial-to-mesenchymal transition (EndMT) contributes to remodeling in LMNA cardiomyopathy by analyzing explanted human LMNA-related dilated cardiomyopathy (LMNA-DCM) hearts. Using spatial transcriptomics and integrated single-nuclei multiomics, it defined endothelial transcriptional/epigenomic states linked to fibrosis and then used patient-specific iPSC-derived endothelial cells and engineered cardiac organoids (along with LMNA models) to test mechanisms. The significance is identifying RUNX1-mediated EndMT as a fibrosis-remodeling pathway in LMNA cardiomyopathy, suggesting a potential therapeutic target to limit fibrotic progression.

Wu D, Tripathi D, Manhas A et al. · European heart journal · (2026) · View on PubMed ↗

Mechanochemical endothelial-astrocyte signalling via Piezo1-Epac1 drives neurovascular injury after stroke.

This research studied how mechanochemical endothelial–astrocyte signaling mediated by Piezo1–Epac1 drives neurovascular injury after stroke. In a transient middle cerebral artery occlusion/reperfusion mouse model, the authors mapped acute shear stress and stiffness remodeling using near-infrared II imaging and atomic force microscopy, and linked these signals to injury mechanisms using in vivo fiber photometry and single-cell transcriptomics. The significance is that Piezo1–Epac1 may be a mechanosensing pathway that can be targeted to prevent neurovascular damage during ischemia-reperfusion injury in stroke.

Liu Y, Sun M, Shen M et al. · Brain : a journal of neurology · (2026) · View on PubMed ↗

miR-221-3p-mediated CPT2 suppression links cardiomyocyte metabolic stress to NET-associated inflammation in myocardial ischemia-reperfusion injury: Multi-omics evidence and experimental validation.

The study investigated how miR-221-3p–mediated suppression of CPT2 connects cardiomyocyte metabolic stress to NET-associated inflammation in myocardial ischemia-reperfusion injury (MIRI) using multi-omics and experimental validation. It combined two-sample Mendelian randomization (MR) and summary-data-based MR to prioritize genes, then used mouse MIRI microarray datasets and cardiac single-cell RNA-seq to infer relevant cell types/signaling, and experimentally validated the miR-221-3p–CPT2 axis linking metabolic dysfunction to NET-associated inflammatory responses. This mechanistic pathway suggests miR-221-3p/CPT2 as a potential target to reduce NET-driven inflammation after MIRI.

Mutailipu M, Aini A, Mutailifu D et al. · International immunopharmacology · (2026) · View on PubMed ↗

The Postcardiac Arrest Inflammatory Response: Mechanisms and Therapeutic Targets.

This Circulation review summarized the post–cardiac arrest inflammatory response, focusing on mechanisms that drive post–cardiac arrest syndrome after return of spontaneous circulation. It highlights systemic ischemia/reperfusion features including endothelial and microvascular dysfunction, vasoplegia, and immune dysregulation that contribute to shock and organ failure, and discusses potential therapeutic targets beyond supportive care. The significance lies in providing a mechanistic roadmap for developing targeted therapies to reduce morbidity and mortality after out-of-hospital cardiac arrest.

Batchelor RJ, Stub D, Donner D et al. · Circulation · (2026) · View on PubMed ↗

---

Cardiometabolic Disease & Obesity/Diabetes Prevention

Evidence based interventions for bipolar disorder across phases and age groups: living umbrella review, evaluation, analysis, and communication hub (U-REACH) project.

This living umbrella review within the U-REACH project systematically evaluated the certainty of evidence for bipolar disorder treatment strategies across age groups and mood phases using systematic reviews (including network and pairwise meta-analyses of randomized trials) of pharmacological, nutraceutical, psychosocial, brain stimulation, and circadian rhythm–based interventions. It aims to synthesize evidence from PubMed, PsycInfo, and the Cochrane Library (inception to 19 Nov 2024) to support shared decision making via an open-access web platform. The work is significant because it translates heterogeneous trial evidence into phase- and age-specific guidance with explicit certainty ratings for clinical decision support in bipolar disorder.

De Prisco M, Oliva V, Miola A et al. · BMJ (Clinical research ed.) · (2026) · View on PubMed ↗

Type 2 diabetes prevention across the life course.

This study examined a life-course framework for type 2 diabetes (T2D) prevention by reframing prevention around prediabetes remission and preservation/restoration of normoglycemia across developmental, behavioral, and environmental exposures. It proposes a “life-course risk architecture” in which progression from normoglycemia to T2D is cumulative and shaped by these determinants, making prediabetes remission an achievable, pragmatic, and measurable prevention target. Clinically, this shifts T2D prevention trials and care goals toward earlier, remission-based endpoints rather than waiting for established dysglycemia.

Wang Y, Sargent JL, Mathieu C et al. · Nature medicine · (2026) · View on PubMed ↗

Oral nano-delivery of a gut microbial metabolite enhances T cell stemness for cancer immunotherapy.

This study investigated an oral nano-emulsion prodrug delivering the gut microbial metabolite 3,4-dihydroxybenzoic acid to enhance adoptive cancer immunotherapy by improving CD8+ T cell stemness. The metabolite suppressed glycolysis and modulated the Akt–mTORC1–Myc pathway, thereby enhancing antitumor immunity and improving the efficacy of adoptive T cell therapy in preclinical experiments. Scientifically and clinically, it provides a drug-like, orally deliverable strategy to reprogram T cell metabolism to boost CAR/T cell-based cancer immunotherapy.

Han K, Cho YS, Takahashi M et al. · Nature nanotechnology · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗

The impact of menstrual cycle phase and BMI on mitochondrial dysfunction in PMOS endometrium.

This study examined oligo-ovulatory women with polyendocrine metabolic ovarian syndrome (PMOS) to determine whether menstrual cycle phase is associated with endometrial transcriptomic changes related to mitochondrial dysfunction, compared with women without PMOS. It found that PMOS endometrium shows menstrual cycle phase-specific transcriptomic dysregulation, most notably involving mitochondrial function. Clinically, this supports a mechanistic link between PMOS and endometrial dysfunction that may contribute to infertility and gestational complications.

Luyckx L, Myllykangas M, Kinnunen J et al. · Human reproduction (Oxford, England) · (2026) · View on PubMed ↗

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated and GRADE Assessed Systematic Review and Meta-Analysis of Randomised Controlled Trials.

This systematic review and meta-analysis evaluated the efficacy and safety of oral PCSK9 inhibitors in adults with hypercholesterolemia using randomized controlled trials. Across trials, it assessed changes in LDL-C and triglycerides as primary outcomes and adverse events and mortality as secondary outcomes, applying PRISMA methods and GRADE assessment. The significance is that it synthesizes comparative evidence to inform whether oral PCSK9 inhibition provides clinically meaningful lipid lowering with acceptable safety in hypercholesterolemic adults.

Khattak MH, Memon S, Bibi H et al. · Diabetes, obesity & metabolism · (2026) · View on PubMed ↗

Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.

This phase 3b randomized, double-blind, placebo-controlled trial (STEP 12) tested once-weekly semaglutide 2.4 mg versus placebo in Chinese adults with overweight or obesity using locally defined BMI thresholds. The study enrolled participants across 19 sites in mainland China and Taiwan and evaluated efficacy, tolerability, and safety (primary outcomes truncated). If effective and well tolerated, semaglutide 2.4 mg would provide an evidence-based anti-obesity pharmacotherapy option for this population.

Guo L, Bao X, Huang KC et al. · The lancet. Diabetes & endocrinology · (2026) · View on PubMed ↗

GDF15 suppresses liver inflammation independently of weight loss through neuroendocrine glucocorticoid signaling.

The study examined whether growth differentiation factor 15 (GDF15) protects against metabolic dysfunction-associated steatohepatitis (MASH) liver injury independently of weight loss using thermoneutral mouse models and genetic deletion of GDF15 or its receptor GFRAL. Genetic loss of GDF15 or GFRAL worsened hepatic inflammation and fibrosis without changing steatosis or insulin resistance, while recombinant GDF15 reduced inflammation and fibrosis more than matched caloric restriction despite identical reductions in food intake, body weight, and steatosis. These findings identify a weight-loss-independent GDF15–GFRAL neuroendocrine glucocorticoid signaling axis as a potential therapeutic target for MASH-associated liver inflammation.

Wang D, Jabile MJT, Di Pastena F et al. · Cell metabolism · (2026) · View on PubMed ↗ · Free PDF ↗

Metabolomics-Defined Subtypes of Prediabetes and Risk of Cardiovascular-Kidney-Metabolic Outcomes.

The study used metabolomics-defined clustering to define biologically distinct prediabetes subtypes and assessed their risk for incident type 2 diabetes, cardiovascular disease, and chronic kidney disease. Using 16 metabolomic biomarkers, it identified three metabolically distinct clusters with progressively increasing risks for these outcomes. The results support metabolomics-based reclassification of prediabetes to better predict cardiometabolic and renal risk beyond clinical phenotypes.

Chen F, Zhang Y, Wang W et al. · Diabetes · (2026) · View on PubMed ↗

Early cigarette smoking reduction and longer-term smoking abstinence in a randomized placebo-controlled e-cigarette trial among people who smoke with no plans to quit.

This exploratory analysis evaluated whether early cigarette reduction predicts longer-term smoking abstinence in adults who smoke but have no plans to quit, using data from a randomized placebo-controlled e-cigarette smoking-reduction trial (N=520) comparing e-cigarettes with 0, 8, or 36 mg/mL nicotine versus a cigarette substitute. The key finding was that early reductions in cigarette consumption were associated with higher likelihood of longer-term smoking abstinence, mirroring patterns previously observed in nicotine replacement therapy reduction trials. Scientifically and clinically, it suggests that early reduction behavior can be used as a prognostic signal for sustained abstinence even among smokers not initially intending to quit.

Dahal S, Yingst J, Mazhar L et al. · Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · (2026) · View on PubMed ↗

---

Biomarkers & Diagnostic/Prognostic Testing (including liquid biopsy)

Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications.

This review synthesized clinical and research evidence on fluid biomarkers in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), emphasizing aquaporin-4 (AQP4)-IgG and MOG-IgG. It reports that these antibodies transformed disease classification and enabled targeted therapy development, while stressing that optimal clinical use requires careful interpretation in the appropriate clinical and radiologic context. The clinical significance is improved diagnostic accuracy and more reliable biomarker-guided management for NMOSD/MOGAD.

Mariotto S, Cobo-Calvo A, Khalil M et al. · Neurology(R) neuroimmunology & neuroinflammation · (2026) · View on PubMed ↗

Intratracheal Delivery of mRNA Lipid Nanoparticles Reprograms Alveolar Macrophages for Pulmonary Cancer Immunotherapy.

This study evaluated whether D-dimer levels are associated with disease severity and contralateral slip risk in slipped capital femoral epiphysis (SCFE) using a single-center retrospective cohort of 25 unilateral SCFE patients (2020–2024). It compared D-dimer and other clinical/laboratory variables (including complete blood count measures) against age- and sex-matched obese controls and healthy subjects with normal BMI, and assessed contributions to existing predictive models. The clinical significance is determining whether D-dimer can serve as a risk stratification biomarker for SCFE severity and future contralateral slip.

Zhou J, Li T, Zhang W et al. · ACS nano · (2026) · View on PubMed ↗

Long-Term Liver Outcomes in Wilson’s Disease: Predictors of Survival and Hepatocellular Carcinoma.

This retrospective longitudinal cohort study analyzed long-term outcomes in 146 patients with Wilson’s disease from a tertiary referral center in Taiwan to identify predictors of survival and hepatocellular carcinoma (HCC). The key findings reported include that a minority of patients required liver transplantation and that deaths occurred during follow-up, with clinical predictors assessed for their association with survival and HCC risk. These data are significant for risk stratification and long-term management planning in Wilson’s disease, particularly regarding surveillance intensity for HCC and transplant timing.

Hsu CT, Fan SP, Wu JF et al. · Clinical and molecular hepatology · (2026) · View on PubMed ↗ · Free PDF ↗

Recombinant Proteins, Multiepitope Constructs, and Synthetic Peptides for ELISA-Based Diagnosis of Leptospirosis: A Comprehensive Review.

This comprehensive review evaluated recombinant proteins, multiepitope constructs, and synthetic peptides as ELISA-based diagnostic tools for leptospirosis caused by pathogenic Leptospira species. It highlights limitations of the WHO-recommended microscopic agglutination test (MAT) and summarizes how ELISAs using engineered antigens aim to improve diagnostic practicality and performance. The scientific significance is that antigen engineering strategies could enable more scalable, accessible leptospirosis diagnostics, especially in resource-limited endemic regions.

Couto CAP, Ferreira LC, Ribeiro AJ et al. · Current medicinal chemistry · (2026) · View on PubMed ↗

Antisense transcription reveals disease-associated adaptations in the human gut microbiome.

This study developed metastrand, a strand-aware metatranscriptomics plus metagenomics framework to quantify sense mRNAs and antisense RNAs (asRNAs) at gene-level resolution in human gut microbiomes, including inflammatory bowel disease (IBD) patients. In active IBD, microbial asRNA programs converged across patients, correlated with fecal metabolites and calprotectin, and remained stable during persistent inflammation, supporting their use as biomarkers of inflammatory activity. The work is significant because it enables gene-level tracking of antisense transcriptional adaptations that may improve monitoring and mechanistic understanding of IBD.

Pust MM, Mohamed AMT, Stražar M et al. · Nature microbiology · (2026) · View on PubMed ↗

An episignature informed systematic analysis to ascertain the clinical significance and consequences of CHD8 missense variants.

This study assessed the clinical significance of CHD8 missense variants in 39 affected patients by systematically applying ACGS/ACMG variant interpretation guidelines to 36 CHD8 missense variants. Only 2 variants were classified as likely pathogenic, while 34 were variants of uncertain significance (VUS), with 14 having at least “tepid” VUS posterior probability of pathogenicity (PPP ≥ 50%); comprehensive phenotyping did not reveal clear clinical differences among categories. The findings highlight the difficulty of interpreting CHD8 missense variants and support the need for improved evidence frameworks and phenotypic stratification for autism/IDDAM genetics.

Godfrey M, Levy MA, Campbell C et al. · European journal of human genetics : EJHG · (2026) · View on PubMed ↗ · Free PDF ↗

Prediction of structural glaucoma progression from baseline fundus photographs using deep learning: a retrospective multicentre study.

This retrospective multicentre study developed and externally validated G-PROG, a deep learning model predicting 2–5-year glaucoma progression from baseline color fundus photographs (CFPs) in patients across multiple glaucoma departments. Trained on UZ Leuven data and tested on external datasets from Belgium, Finland, Germany, and China (161,827 images; 127,962 visits; 13,913 patients), the model aimed to identify individuals at risk of rapid progression. Clinically, it supports scalable, image-based risk stratification to enable earlier intervention and reduce vision loss from glaucoma.

Hemelings R, Wong DW, Chua J et al. · The Lancet. Digital health · (2027) · View on PubMed ↗ · Free PDF ↗

Cardiogenic shock supported with VA-ECMO: Association between cDPP3 concentrations and outcomes in a post hoc analysis of the ADRECMO cohort.

This post hoc analysis assessed whether circulating dipeptidyl peptidase-3 (cDPP3) concentrations predict outcomes in the most severe cardiogenic shock (CS) patients requiring venoarterial ECMO (VA-ECMO) using the ADRECMO prospective cohort. The study focused on associations between cDPP3 levels and clinical outcomes in 50 VA-ECMO–treated CS patients (measurement and results truncated). If validated, cDPP3 could serve as a prognostic biomarker to stratify risk in VA-ECMO–supported CS.

Bruno J, Durand M, Azibani F et al. · Journal of cardiac failure · (2026) · View on PubMed ↗ · Free PDF ↗

A blood-based test for detection of advanced adenomas and colorectal cancer (DENEB): a multicentre diagnostic accuracy study.

This multicentre diagnostic accuracy study (DENEB) evaluated a blood-based assay designed to detect advanced adenomas and colorectal cancer using an outcome-enriched case-control design. It aimed to determine diagnostic performance for premalignant advanced lesions that are critical for preventing colorectal cancer incidence and mortality (full assay details and results truncated). A validated blood test could expand screening participation and improve early detection of advanced adenomas and colorectal cancer.

Mannucci A, Xu C, Balaguer F et al. · The lancet. Gastroenterology & hepatology · (2026) · 1 citations · View on PubMed ↗

Liquid Biopsies for Cancer: A Translational Science Review.

This translational science review synthesized evidence on liquid biopsies using circulating tumor DNA (ctDNA) across multiple cancer types, focusing on how ctDNA sequencing detects tumor gene variants and tracks treatment response. The key finding is that ctDNA levels and variant profiles can be used to monitor progression and residual disease and to guide selection of molecularly directed therapies in cancers such as non-small cell lung cancer, colorectal cancer, and breast cancer. Clinically, this supports ctDNA as an actionable, minimally invasive tool for precision oncology and for identifying resistance/recurrence signals earlier than conventional methods.

Mezzanotte-Sharpe J, Piemonte K, Park BH · JAMA · (2026) · View on PubMed ↗

Plasma Biomarkers for Neocortical Tau Burden.

This study developed and validated a multiprotein plasma panel to better identify advanced neocortical neurofibrillary tangle burden, building on the known limitations of plasma phosphorylated tau-217 (p-tau217) for staging tau pathology. The key finding was that the multiprotein panel improved performance for detecting advanced neocortical tau burden compared with p-tau217 alone. Scientifically and clinically, improved plasma tau staging could enhance patient stratification for anti-amyloid and anti-tau trials and support more rational selection of participants.

Di Molfetta G, Brum WS, Pola I et al. · JAMA neurology · (2026) · View on PubMed ↗

---

Clinical Guidelines & Patient Care Pathways

Palliative care specialists infrequently discuss driving safety with their patients with cancer when prescribing opioids.

This pilot survey study assessed how often palliative care specialists discuss driving safety with cancer patients when prescribing opioids. The key finding was that driving-safety discussions were infrequent among palliative care specialists in routine opioid prescribing contexts. This is clinically significant because opioid initiation or dose increases can impair driving ability, and systematic counseling could improve patient safety and independence.

Bramati PS, Gilbey D, Nkeonye S et al. · Annals of palliative medicine · (2026) · View on PubMed ↗ · Free PDF ↗

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

This phase 3 randomized, double-blind trial evaluated obinutuzumab β (MIL62), a glycoengineered type II anti-CD20 monoclonal antibody, in AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD). In 91 participants aged 18–70 with EDSS ≤7.0, obinutuzumab β 1,000 mg given intravenously was compared with placebo, with the primary endpoint being time to first adjudicated relapse (details truncated in the abstract). The study’s significance lies in providing high-quality evidence for CD20 depletion using a next-generation antibody in a large NMOSD population, potentially informing standard-of-care relapse prevention.

Wu L, Gu L, Fan W et al. · Nature medicine · (2026) · View on PubMed ↗ · Free PDF ↗

The Food Allergy-Eosinophilic Esophagitis Continuum: Implications for Food Allergy Immunotherapy.

This review synthesized evidence on the IgE-mediated food allergy–eosinophilic esophagitis (EoE) continuum in children with IgE-mediated food allergy and during oral immunotherapy. It found that EoE prevalence among children with IgE-mediated food allergy is nearly 100-fold higher than in the general population (4.7% at 4.7% reported in the abstract) and that confirmed EoE during oral immunotherapy occurs in a minority of patients (reported as 1 [truncated]). Framing IgE food allergy and EoE as a continuum has direct implications for risk stratification and management strategies for oral immunotherapy.

Vellaichamy Manian D, Sindher SB, Khavari N et al. · The journal of allergy and clinical immunology. In practice · (2026) · 1 citations · View on PubMed ↗

Long-term risk of metachronous gastric neoplasms after curative endoscopic submucosal dissection for early gastric cancer.

This retrospective cohort study evaluated time-dependent predictive factors and clinicopathological features of late metachronous gastric neoplasms (MGNs) after curative endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). It analyzed patients treated between March 2005 and June 2020, defining MGN as a new gastric neoplasm at a different site more than 12 months after ESD, and used multivariable time-split Cox models to assess risk beyond 5 years (details truncated). The findings aim to improve long-term surveillance and risk stratification for patients after curative ESD.

Park JS, Lee EA, Park JH et al. · Endoscopy · (2026) · View on PubMed ↗ · Free PDF ↗

Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis : A Target Trial Emulation.

This study used a target trial emulation of Taiwan population-wide insurance claims to compare direct oral anticoagulants (DOACs) versus warfarin in patients with atrial fibrillation and mitral stenosis (AF-MS) prescribed between 2011 and 2021. DOAC use showed different 1-year and 5-year effectiveness and safety risks than warfarin (reported as absolute risk differences and risk ratios), addressing a long-standing controversy in AF-MS management. These real-world comparative effectiveness and safety findings are clinically important for guiding anticoagulant choice in AF-MS where evidence has been limited and heterogeneous.

Yang Y, Shen CY, Cheng MC et al. · Annals of internal medicine · (2026) · View on PubMed ↗

Inflammatory Bowel Disease.

This narrative review examined the clinical burden of inflammatory bowel disease (IBD) and the long-term risks driven by chronic inflammation and immunosuppressive therapy in patients managed in primary care and specialty settings. It emphasizes that structured health care maintenance—covering vaccination, cancer screening, bone and cardiometabolic health, nutrition, and psychosocial care—can improve long-term outcomes beyond symptom control. The review is significant because it provides a practical framework for reducing preventable complications in IBD patients over time.

Park SK, Singh S · Annals of internal medicine · (2026) · View on PubMed ↗

HOW I TREAT BLEEDING IN WOMEN AND GIRLS WITH HEMOPHILIA/ HEMOPHILIA CARRIERS.

This clinical review studied how to manage bleeding in women and girls with hemophilia and hemophilia carriers, incorporating the 2021 ISTH update defining women and girls with hemophilia (WGH) by FVIII/FIX levels <0.40 IU/mL. It emphasizes that many symptomatic carriers have clinically meaningful bleeding despite “carrier” status and normal or near-normal factor levels, requiring carrier-specific assessment and treatment strategies. The article is significant because it standardizes practical approaches for diagnosis and individualized hemostatic management in female patients.

Lavin M, Abdul Kadir R, Sidonio RF · Blood · (2026) · View on PubMed ↗

Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study.

This prospective cohort study evaluated recurrence risk after stopping anticoagulation in patients with provoked venous thromboembolism (VTE), using the ISTH classification of major versus minor transient provoking risk factors. Among patients with symptomatic DVT and/or PE who completed ≥3 months of anticoagulation, recurrence risk varied by provoking-factor category rather than being uniformly “low risk.” The findings refine how clinicians estimate recurrence risk and decide on duration of anticoagulation for provoked VTE.

Eichinger S, Eischer L, Kaider A et al. · Blood · (2026) · View on PubMed ↗

Health Communication and Stepped Reminders Interventions for Lung Cancer Screening: A Randomized Clinical Trial.

This pragmatic 2×2 factorial randomized clinical trial tested two patient-centered multilevel interventions—health communication and stepped reminders—versus usual care to improve adherence to annual lung cancer screening (LCS) after normal results, conducted at Kaiser Permanente Washington among patients with normal LCS findings (November 21, 2022 to April 5, 2024). The key finding was that the interventions increased adherence to guideline-concordant annual LCS compared with usual care. This is significant because it offers scalable behavioral strategies to address persistently low annual screening uptake despite long-standing USPSTF recommendations.

Wernli KJ, Anderson ML, Palazzo L et al. · JAMA internal medicine · (2026) · View on PubMed ↗

Management of Exacerbations and Rescue Therapy: A Prespecified Analysis of the Phase 3 Myasthenia Gravis Inebilizumab Randomized Clinical Trial.

This prespecified analysis evaluated exacerbations and rescue therapy (RT) use in participants enrolled in the phase 3 Myasthenia Gravis Inebilizumab Trial (MINT), comparing inebilizumab (an anti-CD19 monoclonal antibody that depletes CD19+ B cells) versus placebo in uncontrolled generalized myasthenia gravis (gMG). The key finding was that inebilizumab reduced the frequency of exacerbations and decreased the need for RT compared with placebo. Clinically, this strengthens the case for inebilizumab as a therapy that not only improves disease control but also lowers acute deterioration requiring rescue treatment.

Nowak RJ, Utsugisawa K, Benatar M et al. · JAMA neurology · (2026) · View on PubMed ↗

First- and Second-Year Outcomes After Nirsevimab Immunization.

This cohort study assessed whether nirsevimab’s effectiveness against RSV lower respiratory tract infection (LRTI)–related hospitalizations persists across consecutive RSV seasons and beyond the first season, and whether nirsevimab exposure is associated with hospitalizations for non-RSV infections and asthma during years 1 and 2. The key finding was that effectiveness observed in the first RSV season was maintained into a new season and that longer-term follow-up provided additional evidence on persistence of protection while monitoring off-target outcomes. This is significant for informing real-world immunization policy and expectations for multi-season RSV protection with nirsevimab.

Gabet A, Kolla E, Tréluyer L et al. · JAMA pediatrics · (2026) · View on PubMed ↗

Clinical practice on treatment of primary traumatic anterior shoulder dislocation: a multidisciplinary guideline.

This multidisciplinary guideline addresses clinical practice for primary traumatic anterior shoulder dislocation, targeting healthcare professionals involved in diagnosis and management. The key finding is the development of an updated patient care pathway covering diagnostic evaluation and management steps intended to optimize outcomes and reduce issues such as re-dislocation. Clinically, it provides a standardized, evidence-informed approach to improve quality of care for a common injury with long-term functional implications.

Van Gastel ML, Hekman KMC, Boon F et al. · Acta orthopaedica · (2026) · View on PubMed ↗ · Free PDF ↗

---

Musculoskeletal, Bone & Rehabilitation (incl. OA/BMD/exercise)

Effects of creatine supplementation with and without exercise and diet intervention on body composition, cognitive function, and markers of health in middle-aged and older adults.

This study examined whether creatine monohydrate (CrM) supplementation (5 g/day) with or without an exercise-and-diet intervention affects body composition, cognitive function, and health markers in 45–65-year-old sedentary and trained middle-aged/older adults. In a double-blind, counterbalanced randomized design comparing CrM versus 5 g/day maltodextrin placebo, CrM was tested as an adjunct to promote more optimal training/adaptation and cognitive/health-related changes during the intervention. If effective, CrM could be a low-cost nutritional strategy to improve musculoskeletal and cognitive outcomes in older adults undergoing lifestyle-based weight loss and exercise programs.

Chun J, Liu Y, Kibler GL et al. · Journal of the International Society of Sports Nutrition · (2026) · View on PubMed ↗ · Free PDF ↗

Ultrasonographic Evaluations of Tendons/Fascia in Lower Limb Lymphedema and Lipedema.

This observational case-control study used ultrasonography to evaluate tendon and plantar fascia changes in lower-limb lymphedema and lipedema and tested associations with edema volume, pain, function, and quality of life. In 53 patients with chronic lower extremity edema and 55 matched controls, ultrasound assessed the Achilles, tibialis posterior, peroneal, and patellar tendons and plantar fascia, with outcomes including LEFS, LYMQOL-Leg, and VAS. The clinical significance is that imaging biomarkers of tendon/fascia remodeling may help characterize disease severity and functional impact in chronic edema conditions.

Uğur AE, Soyupek F, Özçakar L · American journal of physical medicine & rehabilitation · (2026) · View on PubMed ↗

Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization.

This geroscience-guided narrative review synthesized evidence from PubMed/MEDLINE and Embase (2010–May 2026) on non-surgical and minimally invasive therapies for knee osteoarthritis (KOA), framing treatment around phenotype-dependent joint aging mechanisms. The review highlights that targeting processes such as cellular senescence, inflammaging, mitochondrial dysfunction, synovial inflammation, vascular remodeling, and impaired repair capacity may better preserve “joint healthspan,” and it summarizes data including randomized trials and meta-analyses as well as genicular artery embolization. Clinically, the work supports phenotype-informed, mechanism-targeted conservative strategies and positions genicular artery embolization within a geroscience framework for KOA progression management.

Bérczi Á, Szablics FÉ, Hámori D et al. · GeroScience · (2026) · View on PubMed ↗ · Free PDF ↗

Physical Fitness and All-Cause Mortality in Older Adults.

This nationwide cohort study assessed objectively measured physical fitness across multiple domains in community-dwelling adults aged 65 years or older in Taiwan and tested associations with all-cause mortality. The key finding was that better performance on objective fitness measures was associated with lower all-cause mortality risk, indicating that functional capacity provides prognostic information beyond comorbidity burden. This supports incorporating multi-domain fitness assessment into clinical risk stratification for older adults to better estimate physiological reserve.

Wu MC, Hsu CT, Hsu HT et al. · JAMA network open · (2026) · View on PubMed ↗ · Free PDF ↗

Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology.

This 2026 American College of Cardiology Scientific Statement reviews older adults with cardiovascular disease, focusing on how cognitive impairment and frailty co-occur and relate to shared biological aging processes. The key finding is that CVD, cognitive impairment, and frailty should be treated as overlapping manifestations of common mechanisms such as vascular dysfunction, chronic inflammation, and sarcopenia, with consensus-based recommendations for prevention, assessment, and management. This is clinically significant because it reframes care toward integrated evaluation and intervention targeting shared aging biology rather than treating each condition in isolation.

Alexander KP, Damluji AA, Erqou S et al. · Journal of the American College of Cardiology · (2026) · View on PubMed ↗

---

---

Generated automatically on August 12, 2026 from PubMed’s trending articles. Summaries are AI-generated; always consult the original publication for clinical or research decisions.